A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback